LINC01262

Across TCGA pan-cancer cohorts, LINC01262 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC01262 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC01262 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01262 expression acts as an unfavorable survival marker, although some lineages such as STAD and LAML show a favorable association.

ACC, THCA, and LUAD are the cancer types where LINC01262 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.406	0.824	<.001	63	view →
THCA	OS	Tertile	All	0.529	0.927	<.001	54	view →
LUAD	OS	Tertile	III,IV	0.109	0.660	<.001	36	view →
UVM	OS	Tertile	All	0.442	0.968	<.001	36	view →
LIHC	OS	Tertile	II,III,IV	0.179	0.712	<.001	36	view →
KIRC	DFS	Tertile	IV	0.408	0.661	.017	18	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
STAD	OS	Tertile	IV	0.805	0.283	.031	18	view →
UCS	DFS	Tertile	IV	0.318	0.745	.042	18	view →
LAML	DFS	Median	All	0.467	0.286	.009	16	view →
TGCT	DFS	Tertile	All	0.917	0.745	.020	12	view →
THYM	DFS	Tertile	III,IV	0.205	0.774	.007	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC01262–ACC (OS)

Open the ACC breakdown →